Skip to playerSkip to main contentSkip to footer
  • 7/24/2023
Kenanga thinks 7-Eleven got a Caring deal
Transcript
00:00 Following its big news last week, we take a look at convenience store operator 7E, where
00:05 Kenanga Research is keeping its outperformed call after 7-Eleven said it was selling caring
00:10 pharmacy.
00:11 Kenanga did up its target price by 9% to RM2.59.
00:15 TLDR, 7E is selling its 75% stake in caring pharmacy to Big Pharmacy Healthcare for RM637.5
00:23 million cash at a RM850 million valuation in its entirety.
00:29 The deal values the retail pharmacy chain at 19.6 times its historical FY22 PER.
00:36 7-Eleven stated that its cost of investment in the stake is RM423.2 million.
00:42 This implies a disposal gain of RM214.3 million or RM1.30 per share.
00:48 Kenanga is positive on the disposal as it sees little synergy between 7E's CVS operation
00:53 and retail pharmacy business in the first place and believes 7E will be better off redeploying
00:59 its capital and resources towards growing its CVS business.
01:03 In the absence of caring pharmacy sales, Kenanga cuts its FY24 top-line forecast by 54%.
01:09 However, the disposal will be earnings accretive at the net level of 11% on a reduction in
01:15 interest expenses.
01:17 Analyst opinions are mixed on 7E.
01:19 Looking at BOOMberg data, there are two sells, one hold and one buy, which is Kenanga's.
01:24 Target price works out to RM2.12 or 12 cents more than its last close, a possible 6% up
01:29 side which makes sense given the two underperformed calls.
01:32 Thanks for watching.

Recommended

1:51
Up next